WebApr 7, 2024 · Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent … WebApr 10, 2024 · Inovio Pharmaceuticals Inc's market capitalization is $200.28 M by 260.13 M shares outstanding. Is Inovio Pharmaceuticals stock a Buy, Sell or Hold? Inovio Pharmaceuticals stock has...
Did you know?
WebINOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer, and infectious diseases... Find the latest Inovio Pharmaceuticals, Inc. (INO) stock discussion in Yahoo … Discover historical prices for INO stock on Yahoo Finance. View daily, weekly or … See Inovio Pharmaceuticals, Inc. (INO) Environment, Social and Governance … Find out the direct holders, institutional holders and mutual fund holders for … View the basic INO option chain and compare options of Inovio … See Inovio Pharmaceuticals, Inc. (INO) stock analyst estimates, including … Find out all the key statistics for Inovio Pharmaceuticals, Inc. (INO), including … Get the detailed quarterly/annual income statement for Inovio Pharmaceuticals, … See the company profile for Inovio Pharmaceuticals, Inc. (INO) including … INOVIO (NASDAQ:INO), a biotechnology company focused on developing and … WebApr 11, 2024 · Immunological data from recently completed Phase 1b trial will be presented on April 16 th. PLYMOUTH MEETING, Pa., April 12, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer, and …
WebAs of March 2024 Inovio Pharmaceuticals has a market cap of $0.23 Billion . This makes Inovio Pharmaceuticals the world's 5997th most valuable company by market cap … WebJul 19, 2024 · During the Call, Inovio reported cash, cash equivalents and short-term investments of $360.4 million at Q1, 2024 quarter's end, compared to $401.3 million as of December 31, 2024. This shows a...
WebINO (Inovio Pharmaceuticals) Market Cap as of today (March 17, 2024) is $293.95 Mil. Market Cap explanation, calculation, historical data and more INO (Inovio … WebJan 10, 2024 · Inovio closed on January 9, 2024, at $1.59, giving it a market capitalization of $397 million. Given the $282 million in cash, that represents very low investor expectations. I must admit my...
WebApr 6, 2024 · Market Capitalization $200.17 million P/E Ratio N/A Dividend Yield N/A Price Target $2.33 Profile Analyst Ratings Chart Competitors Earnings Financials Insider Trades Institutional Ownership Headlines Options Chain SEC Filings Short Interest Social Media Sustainability Get Inovio Pharmaceuticals News Delivered to You Automatically
WebApr 10, 2024 · The final chart depicts the total crypto market below. Source: TradingView. The total crypto market cap, which is currently slightly above $1.1 trillion, has been showing small volatility for the past three months around the strong barrier close to $1.2 trillion. Although the cap recently tested this mark again, it has remained unbroken so far. black friday stainless steel cookware dealsWebWhen looking at Inovio’s market cap compared to Moderna’s, it shows the huge difference between the two pharmaceuticals: With Inovio at $1.78 billion and Moderna at nearly $89 … black friday stainless steel cookware setsWebInovio Pharmaceuticals is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and … games free minecraft educationWebReal Good Foods ended 2024 with $8 million in cash and $38 million in total liquidity and reported 68% sales growth in FY2024, with sales coming in at $141.6 million. Its Q4 performance was quite solid as well, with revenue of $35.7 million, up 39% year-over-year despite lapping tough comps with 129% growth in the year-ago period. games free minecraft paperWebApr 10, 2024 · Inovio Pharmaceuticals (Nasdaq:INO) - Stock Price, News & Analysis - Simply Wall St Stocks / United States / Pharmaceuticals & Biotech Inovio Pharmaceuticals NasdaqGS:INO Stock Report Last Price US$0.73 Market Cap US$191.4m 7D -7.2% 1Y -77.0% Updated 10 Apr, 2024 Data Company Financials + 4 Analysts INO Stock Overview games free money gamesWeb2 days ago · Market Cap $200.17M Shares Outstanding 260.13M Public Float 255.99M Beta 0.66 Rev. per Employee $55.77K P/E Ratio N/A EPS -$1.1860 Yield N/A Dividend N/A Ex … black friday stanley cupWebApr 14, 2024 · With the market capitalization of Inovio Pharmaceuticals Inc. currently standing at about $223.17 million, investors are eagerly awaiting this quarter’s results, scheduled for May 08, 2024 – May 12, 2024. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. games free monkey